S&P 및 Nasdaq 내재가치 문의하기

Merck & Co., Inc. MRK NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$187.77
+56.5%
Analyst Price Target
$128.54
+7.2%

Merck & Co., Inc. (MRK) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 FRAZIER KENNETH C 470,769 주 보유. 기타 주요 보유자에는 Davis Robert M 및 DeLuca Richard R..

지난 12개월간 내부자는 74 건의 거래를 수행 MRK 주식 — 48 건 매수 (평가액 $16.03M) 및 9 건 매도 (평가액 $17.6M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

MRK 내부자 보유 현황

최대 보유자
FRAZIER KENNETH C
470,769 주
매수 (12개월)
48
$16.03M 평가액
매도 (12개월)
9
$17.6M 평가액
12개월 거래 활동
매수 65%
매도 12%
내부자 주요 보유자
# 이름 직책 보유 주식수 최종 신고일 상대적 규모
1 Frazier Kenneth C Executive Chair 470,769 2022-11-07
100%
2 Davis Robert M Chairman, CEO & President 443,602 2026-02-06
94%
3 Deluca Richard R. EVP&pres, Merck Animal Heallth 160,174 2026-02-06
34%
4 Perlmutter Roger M Exe V-p & Pres, Mrl 151,029 2020-05-05
32%
5 Wendell Peter C Director 124,753 2024-03-29
26%
6 Glocer Thomas H Director 108,293 2026-04-01
23%
7 Weeks Wendell P Director 92,486 2020-04-02
20%
8 Li Dean Y Executive VP & President, Mrl 92,035 2026-02-10
20%
9 Litchfield Caroline EVP & CFO 90,192 2026-01-28
19%
10 Lazarus Rochelle B Director 87,596 2020-04-02
19%
11 Zachary Jennifer EVP, General Counsel 68,916 2026-01-28
15%
12 Guindo Chirfi Chief Marketing Officer 60,615 2026-02-12
13%
13 Russo Patricia F Director 58,523 2025-06-03
12%
14 Brun Leslie A Director 49,719 2021-06-02
11%
15 Gerberding Julie L. EVP, Chief Patient Officer 48,712 2022-02-28
10%
16 Mizell Steven EVP, Chief HR Officer 41,319 2024-01-24
9%
17 Cech Thomas R Director 40,238 2020-06-02
9%
18 Clyburn Frank EVP & Pres ? Human Health 39,479 2021-11-04
8%
19 Rothman Paul Director 31,991 2025-06-03
7%
20 Craig Pamela J. Director 31,991 2025-06-03
7%
최근 거래 (최근 12개월)
날짜 이름 직책 유형 주식수 주가 금액
2026-03-31 Seidman Christine E Director RSU 부여 68 - -
2026-03-31 Coe Mary Ellen Director RSU 부여 249 - -
2026-03-31 Glocer Thomas H Director RSU 부여 405 - -
2026-03-02 Foard Brian Officer 알 수 없음 - - -
2026-02-12 Guindo Chirfi Chief Marketing Officer 정보 매도 10,000 $121.46 $1.21M
2026-02-10 Li Dean Y Executive VP & President, Mrl 정보 매도 10,235 $117.52 $1.2M
2026-02-09 Zachary Jennifer EVP, General Counsel 옵션 행사 (매도) 38,835 $87.10 $3.38M
2026-02-09 Guindo Chirfi Chief Marketing Officer 정보 매도 10,000 $118.41 $1.18M
2026-02-04 Smart Dalton E. Iii SVP Fin. - Global Controller 옵션 행사 (매도) 4,000 $62.07 $248.28K
2026-02-06 Oosthuizen Johannes Jacobus President, U.s. Market 정보 매도 15,000 $121.87 $1.83M
2026-02-04 Litchfield Caroline EVP & CFO 옵션 행사 (매도) 41,997 $53.06 $2.23M
2026-02-04 Li Dean Y Executive VP & President, Mrl 옵션 행사 (매도) 15,087 $56.04 $845.48K
2026-02-06 Williams David Michael EVP,chief Info&digital Officer 옵션 행사 (매도) 5,000 $77.62 $388.1K
2026-02-05 Guindo Chirfi Chief Marketing Officer 정보 매도 20,000 $121.88 $2.44M
2026-02-06 Deluca Richard R. EVP&pres, Merck Animal Heallth 정보 매도 37,685 $120.92 $4.56M
2026-02-04 Davis Robert M Chairman, CEO & President 정보 매도 32,462 $118.35 $3.84M
2026-01-26 Smart Dalton E. Iii SVP Fin. - Global Controller RSU 부여 1,066 $107.40 $114.49K
2026-01-26 Romanelli Joseph President, Human Health Int?l RSU 부여 5,703 $107.40 $612.5K
2026-01-26 Oosthuizen Johannes Jacobus President, U.s. Market RSU 부여 5,026 $107.40 $539.79K
2026-01-26 Litchfield Caroline EVP & CFO RSU 부여 15,852 $107.40 $1.7M
2026-01-26 Li Dean Y Executive VP & President, Mrl RSU 부여 20,469 $107.40 $2.2M
2026-01-26 Williams David Michael EVP,chief Info&digital Officer RSU 부여 6,112 $107.40 $656.43K
2026-01-26 Zachary Jennifer EVP, General Counsel RSU 부여 11,583 $107.40 $1.24M
2026-01-26 Guindo Chirfi Chief Marketing Officer RSU 부여 9,865 $107.40 $1.06M
2026-01-26 Chattopadhyay Sanat Exe V-p & Pres. Mmd RSU 부여 13,880 $107.40 $1.49M
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기